Navigation Links
Reportlinker Adds RNAi Drug Delivery: Technologies and Global Markets
Date:3/24/2011

to 2015 across RNAi market segments, reviews the latest advances in RNAi drug delivery technologies, and assesses the competitive landscape across RNAi therapeutic areas.

REASONS FOR DOING THE STUDY

Since its discovery in 1998 by two scientists, the naturally occurring RNA interference effect has been hailed as the hottest technical breakthrough in biological research. It may even surpass polymerase chain reaction (PCR) as a top technology. RNA interference allows scientists to silence the expression or effect of a gene being studied. Known simply as RNAi, this field has rapidly emerged as a fast-growing new market. This report assesses this emerging commercial market and maps the key RNAi therapeutic and drug delivery players on the market landscape. The initial companies produced reagents and kits for the biological research reagents market to support basic and applied research in academia, government, and industry. A number of companies decided to take the long road to develop therapeutics. Others have developed drug delivery approaches for emerging RNAi therapeutics. This report analyzes emerging RNAi molecules and delivery technologies and examines new molecular targets and pipeline drugs. It also evaluates competitors and collaborators in the developing RNAi technologies and examines the latest RNAi-related patenting trends.

SCOPE OF REPORT

The latest trends in RNAi therapeutics are examined, focusing on the main areas of clinical need, general/proprietary technologies, and company pipelines, and the activities and strategies of RNAi-based developers are profiled. This report also provides forecasts for market growth to 2015 across major RNAi market segments. This report provides an in-depth assessment of recent progress and future opportunities for RNAi players in major therapeutic areas.

INTENDED AUDIENCE

This report is an exhaustive study
'/>"/>

SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related medicine technology :

1. Reportlinker Adds Global Vitamins Industry
2. Reportlinker Adds US Medical Adhesives And Sealants Industry
3. Reportlinker Adds Global Microscopes Industry
4. Reportlinker Adds Global Imaging Agents Industry
5. Reportlinker Adds Global Stethoscopes Industry
6. Reportlinker Adds Global Micro-Electromechanical Systems (MEMs) Devices Industry
7. Reportlinker Adds U.K. Market for Dental Prosthetics and CAD/CAM Devices 2011
8. Reportlinker Adds Global Cardiac Monitoring Systems Market -2013
9. Reportlinker Adds Medical Devices Market in Europe 2008-2012
10. Reportlinker Adds A Global Overview of Herbal/Traditional Products
11. Reportlinker Adds Methicillin-Resistant Staphylococcus Aureus (MRSA) Therapeutics - Pipeline Assessment and Market Forecasts to 2017
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... , Aug. 27, 2014 IRIDEX Corporation (NASDAQ: ... James H. Mackaness is scheduled to make an investor ... at 2:55 p.m. Eastern Time on Wednesday, September 3, in ... of the investor presentation will be available in the Investors ... About IRIDEX IRIDEX Corporation was founded ...
(Date:8/27/2014)...   Auxilium Pharmaceuticals , Inc. (NASDAQ: ... announced that certain members of the executive management team ... be held September 8-10, 2014 in New ... Officer and President, is scheduled to present an overview ... a.m. ET on Wednesday, September 10, 2014. ...
(Date:8/27/2014)... Calif. , Aug. 27, 2014 Asterias ... U.S. Food and Drug Administration (FDA) to initiate a ... patients with complete cervical spinal cord injury.  The approved ... clinical study of the product, and is designed to ... in patients with complete cervical spinal cord injuries, the ...
Breaking Medicine Technology:Auxilium Pharmaceuticals, Inc. To Present At The Morgan Stanley Healthcare Conference 2Auxilium Pharmaceuticals, Inc. To Present At The Morgan Stanley Healthcare Conference 3Asterias Biotherapeutics Receives U.S. FDA Clearance to Initiate Phase 1/2a Clinical Trial of AST-OPC1 in Patients with Cervical Complete Spinal Cord Injury 2Asterias Biotherapeutics Receives U.S. FDA Clearance to Initiate Phase 1/2a Clinical Trial of AST-OPC1 in Patients with Cervical Complete Spinal Cord Injury 3Asterias Biotherapeutics Receives U.S. FDA Clearance to Initiate Phase 1/2a Clinical Trial of AST-OPC1 in Patients with Cervical Complete Spinal Cord Injury 4Asterias Biotherapeutics Receives U.S. FDA Clearance to Initiate Phase 1/2a Clinical Trial of AST-OPC1 in Patients with Cervical Complete Spinal Cord Injury 5
... Highlights from Avanafil Development Program Include: ... trials Comparative in-vitro selectivity of avanafil, sildenafil, ... post-prostatectomy population VIVUS, Inc. (NASDAQ: ... presented at the Sexual Medicine Society of North America (SMSNA) ...
... Campden Publishing Ltd today launched its medical and educational ... with the launch, Campden Health Communications has separately announced ... that enables its readers to upload video content directly ... magazine image. This is the first time the ,Aurasma, ...
Cached Medicine Technology:Avanafil Data to be Presented at the Sexual Medicine Society of North America Meeting 2Avanafil Data to be Presented at the Sexual Medicine Society of North America Meeting 3Avanafil Data to be Presented at the Sexual Medicine Society of North America Meeting 4Avanafil Data to be Presented at the Sexual Medicine Society of North America Meeting 5Campden Publishing Unveils new Med Comms Division and World-First Technology Licence 2
(Date:8/27/2014)... Los Angeles, CA (PRWEB) August 27, 2014 ... everyone. To do this, Jaha invested in creating the industry’s ... motivation by adding functions that no other apps possess. ... with a tracker that differentiates in three simple steps: locate, ... will launch on Tuesday, Aug 26, 2014 to garner support ...
(Date:8/27/2014)... The Global and China Maleic Anhydride ... current state of the Maleic Anhydride industry in Global ... of the industry, including definitions, applications and industry chain ... are provided with a focus on history, developments, trends ... the international and Chinese situation is also offered. Get ...
(Date:8/27/2014)... New Haven, CT (PRWEB) August 27, 2014 ... , CRN International is about to shed some light on ... exclusive research to members of the Brand Activation Association ... The 40-year-old marketing company polled hundreds of consumers to learn ... have the biggest impact on influencing a potential buying decision. ...
(Date:8/27/2014)... 2014 BCC Research ( http://www.bccresearch.com ) ... IMPLANTS AND REGENERATIVE PRODUCTS , the global market for ... billion by 2014-end to $42.2 billion by 2019, with ... 2014 to 2019. New technologies and an increasingly older ... the market. , While there are many conventional and ...
(Date:8/27/2014)... HealthDay Reporter TUESDAY, Aug. 26, 2014 ... for blood transfusions might also protect the brains of premature ... stimulates red blood cell production, appears to prevent brain damage ... Petra Huppi, a professor of pediatrics and newborn medicine at ... of whether EPO protects the brains of these children will ...
Breaking Medicine News(10 mins):Health News:Jaha, Inc. The Most Affordable Fitness Band in the Market Released on Kickstarter 2Health News:Maleic Anhydride Industry & Isoprene Market Global and China Analysis Now Available at ReportsnReports.com 2Health News:Maleic Anhydride Industry & Isoprene Market Global and China Analysis Now Available at ReportsnReports.com 3Health News:Maleic Anhydride Industry & Isoprene Market Global and China Analysis Now Available at ReportsnReports.com 4Health News:Maleic Anhydride Industry & Isoprene Market Global and China Analysis Now Available at ReportsnReports.com 5Health News:CRN Set To Release Poll Results On What Marketing Tactics Prompt Consumers To Buy 2Health News:Global Market for Advanced Orthopedic Technology to Reach $42.2 Billion in 2019; Biotechnological Advancements Driving the Market 2Health News:Global Market for Advanced Orthopedic Technology to Reach $42.2 Billion in 2019; Biotechnological Advancements Driving the Market 3Health News:Hormone Might Help Preemies' Brains 2Health News:Hormone Might Help Preemies' Brains 3
... ARBOR, Mich.---Persons with alcohol problems are finding comfort in ... shows. Among 1,910 people with any alcohol-related problems, ... researchers at the University of Michigan Health System and ... who used services from clergy also used professional services ...
... Today during the 88th General Session & Exhibition ... Spain, presenting author J. Meyle, Justus Liebig University, Giessen, ... Infection and Immune Evasion of Oral Carcinomas." ... oral cancers and periodontal disease. They achieved results by ...
... By Steven Reinberg HealthDay Reporter , TUESDAY, ... long shadow. Those who survive the original cancer are ... new cancers, heart disease and stroke likely caused by ... more children are surviving cancer, many have long-term risks ...
... associated with cancer symptoms often unrecognized and ... telephone-based care management coupled with automated symptom monitoring, ... Indiana University School of Medicine. The Indiana ... calls with follow-up calls from the nurse care ...
... A report issued by the Program on International Health ... Health proposes a new research agenda to address the ... "The Pregnancy Intentions of HIV-Positive Women: Forwarding the ... urges a multi-disciplinary research approach to help HIV-positive women ...
... By Amanda Gardner HealthDay Reporter , TUESDAY, ... the safety of controversial diabetes drug Avandia, members of the ... skeptical of much of the data presented. A decision ... The hearing has coincided with news that the drug,s ...
Cached Medicine News:Health News:Individuals confess alcohol abuse to clergy 2Health News:Childhood Cancer Survivors at Risk of Premature Death 2Health News:Childhood Cancer Survivors at Risk of Premature Death 3Health News:Help is on the phone: Reducing pain and depression of cancer 2Health News:Report proposes new research agenda on pregnancy intentions of HIV-positive women 2Health News:Report proposes new research agenda on pregnancy intentions of HIV-positive women 3Health News:FDA Panel Seems Skeptical Over Key Avandia Data 2Health News:FDA Panel Seems Skeptical Over Key Avandia Data 3Health News:FDA Panel Seems Skeptical Over Key Avandia Data 4
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: